Скачать с ютуб Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest - Morning Sessions в хорошем качестве

Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest - Morning Sessions

The Reagan-Udall Foundation for the FDA, in collaboration with the FDA, hosted a hybrid public workshop on "Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest." This public workshop explored topics such as the scope of ketamine use, including approved products and compounded products, for these emerging areas of therapeutic interest; potential safety concerns; and online promotion of and access to ketamine. Speakers included clinicians, academic researchers, and federal partners. Opening Remarks - 0:26 Session 1: Overview of the Changing Ketamine Landscape - 10:55 Session 2: Scope of Ketamine Use in Clinical Practice - 28:55 Session 3: Identifying Safety Concerns and Potential Risks Associated with the Use of Ketamine Products - 2:00:03